Clinical Trials Browser

Phase 3 × Completed × Anorexia × Clear all

NCT05243251 2024-10-03

Olanzapine Anorexia Cachexia

Phase 3 Completed

Anorexia

NCT00006799 2021-09-09

Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer

Phase 3 Completed

Squamous Cell Carcinoma of Head and Neck, Anorexia, Cachexia, Head and Neck Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00031785 2021-09-09

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer

Phase 3 Completed

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00081250 2020-04-29

Creatine in Treating Patients With Cancer-Associated Weight Loss

Phase 3 Completed

Anorexia, Body Weight Changes, Cachexia

NCT00040885 2016-12-07

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Phase 3 Completed

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms

NCT00031707 2016-07-14

Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite

Phase 3 Completed

Anorexia, Cachexia

NCT00513357 2012-12-11

Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients

Phase 3 Completed

82 enrolled 7 charts

GastrointestinalThoracic

Anorexia, Cachexia, Gastrointestinal Neoplasms, Lung Neoplasms, Weight Loss

NCT00046904 2011-05-05

Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer

Phase 3 Completed

Anorexia, Cachexia